Sr. No. Particulars as per SEBI (LODR) Weblink
1 Details of business https://www.aartipharmalabs.com/products-and-services
2 Terms and conditions of Appointment of Independent Directors https://www.aartipharmalabs.com/investors/terms-and-conditions-of-appointment-of-independent-director.pdf
3 Composition of Committees of Board of Directors https://www.aartipharmalabs.com/investors/composition-of-committees.pdf
4 Code of Conduct  https://www.aartipharmalabs.com/investors/code-of-conduct-feb-2023.pdf
5 Vigil mechanism/ Whistle Blower policy https://www.aartipharmalabs.com/investors/vigil-mechanism-policy-feb-2023.pdf
6 Criteria for making payment to Non Executive Directors https://www.aartipharmalabs.com/investors/nomination-and-remuneration-policy-feb-2023.pdf
7 Policy on Related Party Transactions https://www.aartipharmalabs.com/investors/rpt-policy-feb-2023.pdf
8 Policy for determining Material Subsidiaries https://www.aartipharmalabs.com/investors/policy-on-determination-of-material-subsidiary-feb-2023.pdf
9 Familiarization programmes imparted to Independent Directors https://www.aartipharmalabs.com/investors/familiarization-programme-fy2022-23.pdf
10 Contact details for Grievance Redressal https://www.aartipharmalabs.com/investors-relations
11 Financial Information https://www.aartipharmalabs.com/quarterly-results
12 Shareholding Pattern https://www.aartipharmalabs.com/shareholding-pattern
13 Details of agreements entered into with the media companies and/or their associates No such agreements were entered into with the media companies and/or their associates.
14 Details of analysts or institutional investors meet No analysts or institutional investors meet were conducted nor any presentations were made to analysts or institutional investors.
15 New Name and Old name of the Company https://www.aartipharmalabs.com/
16 Disclosures under Regulation 47(1) of LODR https://www.aartipharmalabs.com/newspaper-advertisement
17 Credit Rating https://www.aartipharmalabs.com/credit-ratings
18 Subsidiary Financial Statements https://www.aartipharmalabs.com/subsidiary-companies-balance-sheets
19 Secretarial Compliance Report https://www.aartipharmalabs.com/secretarial-compliance-report
20 Materiality Policy https://www.aartipharmalabs.com/investors/policy-on-materiality-of-events-feb-2023.pdf
21 Contact details of KMP for determining materiality https://www.aartipharmalabs.com/investors-relations
22 Disclosures under Regulation 30(8) of SEBI
(LODR) Regulations, 2015
https://www.aartipharmalabs.com/material-and-recent-news
23 Dividend Distribution Policy https://www.aartipharmalabs.com/investors/dividend-distribution-policy-feb-2023.pdf
24 Annual Return https://www.aartipharmalabs.com/annual-return